FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Omega-3-Acid Ethyl Esters Capsules Recall

Omega-3-Acid Ethyl Esters Capsules USP, 1 gram* 120-count bottle Rx Only

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Aug 15, 2018
Recall ID
D-1074-2018
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Omega-3-Acid Ethyl Esters Capsules starting Jul 16, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1074-2018 on Aug 15, 2018. Reason: API material used in the manufacturing of the product did not receive regulatory approval prior to release. Status: Terminated.

Why it was recalled

API material used in the manufacturing of the product did not receive regulatory approval prior to release.

Product description

Omega-3-Acid Ethyl Esters Capsules USP, 1 gram* 120-count bottle Rx Only. Manufactured by: Banner Pharmacaps, Inc. High Point, NC 27265. Manufactured for: Teva Pharmaceuticals USA Inc. North Wales, PA 19454 NDC 0093-5401-89

Lot numbers, UPCs & expiration codes

Lot # 150001420A, EXP 2/2019

Where it was sold

Product was distributed throughout the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1074-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 16, 2018
FDA report date
Aug 15, 2018
Quantity
13,715 120-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-1074-2018, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
80550
Address
1090 Horsham Rd
Code information
Lot # 150001420A, EXP 2/2019
Postal code
19454-1505
Report date
Aug 15, 2018
Product type
Drugs
Recall number
D-1074-2018
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
13,715 120-count bottles
Termination date
Mar 28, 2019
Reason for recall
API material used in the manufacturing of the product did not receive regulatory approval prior to release.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Omega-3-Acid Ethyl Esters Capsules USP, 1 gram* 120-count bottle Rx Only. Manufactured by: Banner Pharmacaps, Inc. High Point, NC 27265. Manufactured for: Teva Pharmaceuticals USA Inc. North Wales, PA 19454 NDC 0093-5401-89
Distribution pattern
Product was distributed throughout the United States
Recall initiation date
Jul 16, 2018
Initial firm notification
Letter
Center classification date
Aug 8, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1074-2018, published Aug 15, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls